It was reported that the procedure was to treat a 75% de novo lesion in a mildly tortuous and mildly calcified right renal artery.Reportedly, after deployment of a rx herculink elite 6x15mm stent, a dissection was observed at the distal-end of the deployed stent.Another stent was deployed to overlap and cover the dissection.Post-procedure renal artery stenosis was 5%.There were no reported adverse patient sequelae and no reported significant clinical delay in the procedure.No additional information was provided.
|
(b)(4).There was no reported device malfunction and the product was not returned.The reported patient effect of dissection is a known observed and potential patient effect as listed in the rx herculink elite instructions for use.Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.
|